Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin.
Anticancer Drugs
; 20(1): 75-8, 2009 Jan.
Article
em En
| MEDLINE
| ID: mdl-19343004
ABSTRACT
Alpha-fetoprotein-producing metastatic adenocarcinoma of the stomach or the esophago-gastric junction usually exhibits either no or only short-term remission while receiving palliative chemotherapy. We report on a 76-year-old male patient suffering from an unresectable alpha-fetoprotein-producing adenocarcinoma of the esophago-gastric junction with several liver metastases. He was treated with capecitabine and oxaliplatin-based combination therapy. A long-lasting major remission was observed resulting in a survival of 18.5 months.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Esofágicas
/
Adenocarcinoma
/
Alfa-Fetoproteínas
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Junção Esofagogástrica
/
Neoplasias Hepáticas
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2009
Tipo de documento:
Article